Use case
Enterprise AI platform or compliance staff, after agents are connected to internal systems, work through agent runtime logs and permission records to confirm whether a given automated action exceeded authority and to leave an auditable conclusion.
Today this is mostly manual log sampling, added approval steps in the workflow, or simply restricting agent permissions.
When agents act automatically, people cannot easily review step by step which systems they called and with what permissions, and after an incident there is little traceable record.
xOcto's call
Problem identified, demand strength unclear
The trend is agents moving from demos into enterprise execution, which makes governance and audit a purchase item before scale. An entry point is platform teams in regulated sectors such as finance and healthcare who own agent rollout; pricing could plausibly be per governed agent or per audit report, but no price is disclosed, so this is inference.
Reason to use it
Why users would choose it
Inference: if it records and blocks out-of-scope calls at runtime, it could remove the manual log-trawling step and hand compliance staff an auditable conclusion; however the public material does not describe blocking rules, report format or human confirmation, so it is not yet established that users would choose it for this.
Where the easy answer breaks down
The tension worth following
An English validation note will follow from the public evidence.
If this is your job
Keep watching. Inference: if it records and blocks out-of-scope calls at runtime, it could remove the manual log-trawling step and hand compliance staff an auditable conclusion; however the public material does not describe blocking rules, report format or human confirmation, so it is not yet established that users would choose it for this.
Entry and what to borrow
The trend is agents moving from demos into enterprise execution, which makes governance and audit a purchase item before scale. An entry point is platform teams in regulated sectors such as finance and healthcare who own agent rollout; pricing could plausibly be per governed agent or per audit report, but no price is disclosed, so this is inference.